Carey Danis & Lowe Pelvic Mesh Lawyers Weigh in on Ethicon MDL 2327 and Gynecare Prolift Mesh Lawsuit Removal Request
Published April 25, 2013 by PR Web St. Louis, Missouri (PRWEB) April 25, 2013 Pelvic mesh lawyers at Carey Danis & Lowe continue to follow Ethicon MDL 2327 proceedings currently taking place in the U.S. District Court for the Southern District of West Virginia, as the law firm represents women who have been injured by defective pelvic mesh. A recent update in the Ethicon MDL involves a pretrial order issued by Chief Judge Robert C. Chambers and U.S. District Judge Joseph R. Goodwin. The order pertains to the judge responsible for Continue Reading
Carey Danis & Lowe Examines FDA Pradaxa Safety Review
Submit Your Claim The U.S. Food and Drug Administration (FDA) recently published a report about the safety of Pradaxa in The New England Journal of Medicine. The article’s intention was to more thoroughly examine the health risks associated with Pradaxa use, especially in light of the increasing reports linking Pradaxa to excessive bleeding and death. The study that won Pradaxa FDA approval in October 2010, the Randomized Evaluation of Long-Term Anticoagulation Therapy, or RE-LY, trial compared Pradaxa to warfarin. The RE-LY trial results concluded there to be no difference Continue Reading
Carey Danis & Lowe Optimistic About DePuy ASR Hip Lawsuits Following Johnson & Johnson Loss
Submit Your Claim Published March 19, 2013 by PR Web St. Louis, Missouri (PRWEB) March 19, 2013 With defective medical device lawyers currently investigating DePuy ASR Hip Replacement system cases, Carey Danis & Lowe is optimistic about the future of DePuy ASR Hip lawsuits that go to trial. Kransky v. DePuy, a case being heard in a California Superior Court in Los Angeles, involved the plaintiff, Loren Kransky, and resulted in Kransky receiving a compensatory award of $8.3 million, according to a New York Times report on the [DePuy trial]. Though the Continue Reading
Lawyers at Carey Danis & Lowe Currently Evaluating Mirena Cases
Submit Your Claim Published February 20, 2013 by PR Web St. Louis, Missouri (PRWEB) February 20, 2013 To address the increasing number of adverse event reports associated with the use of the Mirena intrauterine device manufactured by Bayer(1), lawyers at Carey Danis & Lowe have launched a new website with useful information for individuals who may have used the Mirena IUD or know someone who has used the contraceptive device. The new webpage has information about health complications associated with use of Bayer’s Mirena IUD. In Carey Danis & Continue Reading
Wellbutrin Claims and Topamax Claims on the Rise at Carey Danis & Lowe
Submit Your Claim Published October 31, 2012 by PR Web St. Louis, MO (PRWEB) October 31, 2012 Pharmaceutical product liability lawyers at Carey Danis & Lowe have announced that they are undertaking an investigation into Wellbutrin claims. Attorneys at Carey Danis & Lowe are asking that individuals and families contact the law firm if they feel their child, or the child of a loved one, was born with a congenital heart defect due to the use of Wellbutrin during pregnancy. Wellbutrin is a drug manufactured by GlaxoSmithKline, and is used in to Continue Reading
Carey Danis & Lowe Issues an Update on the Pradaxa Multi-District Litigation No. 2385
Submit Your Claim Published December 27, 2012 by PR Web St. Louis, MO (PRWEB) December 27, 2012 Pradaxa lawsuits have been consolidated into a Multi-District Litigation being heard in the U.S. District Court, Southern District of Illinois. The Pradaxa MDL has been named Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation. The last Pradaxa MDL meeting occurred on Thursday, December 13, 2012, where Plaintiffs’ representatives as well as the Defendants’ legal counsel convened for a Status Conference. The MDL No. 2385 is presided over by Chief Judge David R. Herndon Continue Reading
Carey Danis & Lowe Evaluating Zoloft Cases and Offers an Update on Zoloft Lawsuits in Zoloft MDL No. 2342
Submit Your Claim Published January 14, 2013 by PR Web St. Louis, Missouri (PRWEB) January 14, 2013 Zoloft lawsuits have been consolidated into a Multi-District Litigation in the U.S. District Court for the Eastern District of Pennsylvania. Judge Cynthia M. Rufe is presiding over the Zoloft MDL. As to recent developments in the Zoloft MDL, on January 2, 2013, Judge Rufe sent forth Pretrial Order No. 16. Fundamentally, the Pretrial Order outlines how to deliver responses in the MDL. The court document imparts detailed information as to “the procedure Continue Reading
Carey Danis & Lowe Lawyers Examine the Link Between Actos and Bladder Cancer
Published November 29, 2012 by PR Web St. Louis, Missouri (PRWEB) November 29, 2012 November is American Diabetes Month and the pharmaceutical product liability lawyers at Carey Danis & Lowe are examining the relationship of Actos and bladder cancer. In recent months, the European Medicines Agency and the U.S Food and Drug Administration (FDA) have reviewed the safety of the drug and its potential to cause bladder cancer. Based on these studies, Carey Danis & Lowe provides consultation to those who may have been harmed by Actos and may Continue Reading
Pharmaceutical Product Liability Attorneys at Carey Danis & Lowe Investigating Pradaxa Lawsuits
Published August 27, 2012 on PR Web St. Louis, Missouri (PRWEB) August 27, 2012 For individuals who have incurred injuries from Pradaxa use, attorneys at Carey Danis & Lowe are currently accepting claims against the blood thinning drug’s German manufacturer, Boehringer Ingelheim. The anticoagulant Pradaxa, known as a direct thrombin inhibitor, was approved for use by the U.S. Food and Drug Administration (FDA) in October 2010. Since that time, Boehringer Ingelheim developed the drug with the intention that it would be a suitable and potentially superior replacement for Warfarin, Continue Reading
Carey Danis & Lowe Attorneys Investigate Lexapro Birth Defect Link
Published June 28, 2012 by PR Web St. Louis, Missouri (PRWEB) June 28, 2012 Attorneys at Carey Danis & Lowe are currently investigating claims that link an antidepressant drug, known as Lexapro, to birth defects in newborns. Lexapro is an antidpressant drug developed and manufactured by Forest Laboratories, a pharmaceutical company headquartered in New York. According to a warning issued by the Food & Drug Administration (FDA) in 2005, selective serotonin reuptake inhibitor (SSRI) antidepressant drugs, such as Lexapro, have been linked to an increased risk of birth defects Continue Reading
